While much recent attention has been given to the Cancer Moonshot research effort, the National Cancer Institute established a network of publicly funded cancer cooperative research groups more than 50 years ago to evaluate new treatments for efficacy and safety. JAMA Oncology details an investigation that examined the extent to which positive NCI-sponsored cancer treatment trials have benefitted patients with cancer. The study estimated that 3.34 million life-years were gained in the population of U.S. patients with cancer through 2015, at a cost of $125 per life-year gained. Twenty-three treatment trials were identified as providing a statistically significant improvement in overall survival from new, experimental therapies developed from 1956-2016.
